Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study-Reference-Cited by-同舟云学术

Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study

Published:2020-07 Issue: Volume:134 Page:90-98
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Chen Shiguang,Zhang Kongzhi,Liu Weifu,Yu Wenchang^ORCID

Funder

Guiding Project of Science and Technology Program of Fujian Province, China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Hepatocellular carcinoma;Forner;Lancet,2018

3. A comparative study between sorafenib and hepatic arterial Infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis;Song;J Gastroenterol,2015

4. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis;Choi;Cancer Chemother Pharmacol,2018

5. Effcacy and safety of sorafenib in patients in the Asia-Pacifc region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study;ImmunoTargets and Therapy;2024-08

2. Clinical Effectiveness and Safety of Transarterial Chemoembolization: Hepatic Artery Infusion Chemotherapy Plus Tyrosine Kinase Inhibitors With or Without Programmed Cell Death Protein-1 Inhibitors for Unresectable Hepatocellular Carcinoma—A Retrospective Study;Annals of Surgical Oncology;2024-08-01

3. Short-term efficacy of oxaliplatin as interventional therapy for liver cancer, and its effect on serum CD163 and AFU;Tropical Journal of Pharmaceutical Research;2024-03-12

4. Transradial access for hepatic artery infusion chemotherapy: a single center retrospective study;2024-02-27

5. The Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Near-term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy: A Propensity Score Matching Cohort Study;2024-01-18